LCADA Way Womens Residential Services

LCADA Way Womens Residential Services

Services:
Type of Opioid Treatment
• Buprenorphine maintenance
• Accepts clients using MAT but prescribed elsewhere
• Prescribes naltrexone
• Prescribes buprenorphine
• Lofexidine or Clonidine detoxification
• Buprenorphine detoxification

Other Services

• Treatment for gambling disorder

Special Programs/Groups Offered

• Clients who have experienced trauma
• Pregnant/postpartum women
• Adult women
• Clients with co-occurring mental and substance use disorders

Detoxification (medical withdrawal) Services

• Methamphetamines detoxification
• Medication routinely used during detoxification
• Cocaine Detoxification
• Opioids detoxification

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Type of Care

• Substance use treatment
• Detoxification

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient methadone/buprenorphine or naltrexone treatment
• Long-term residential
• Regular outpatient treatment
• Outpatient day treatment or partial hospitalization
• Residential/24-hour residential
• Intensive outpatient treatment
• Short-term residential
• Outpatient detoxification
• Outpatient

Gender Accepted

• Female
• Male

Ancillary Services

• Suicide prevention services
• Child care for clients’ children
• Mental health services
• Case management service
• Early intervention for HIV
• Social skills development
• Transportation assistance
• Residential beds for clients’ children
• Domestic violence services, including family or partner

Testing

• Breathalyzer or blood alcohol testing
• Drug or alcohol urine screening

Facility Smoking Policy

• Smoking permitted in designated area

Treatment Approaches

• Cognitive behavioral therapy
• Telemedicine/telehealth therapy
• Motivational interviewing
• Trauma-related counseling
• Contingency management/motivational incentives
• Matrix Model
• Relapse prevention
• Substance use disorder counseling

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Facility Vaping Policy

• Vaping permitted in designated area

Payment/Insurance/Funding Accepted

• Medicaid
• Cash or self-payment
• SAMHSA funding/block grants
• Federal, or any government funding for substance use treatment programs
• Private health insurance
• State-financed health insurance plan other than Medicaid

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Education and Counseling Services

• Hepatitis education, counseling, or support
• Substance use disorder education
• Health education services other than HIV/AIDS or hepatitis
• Individual counseling
• HIV or AIDS education, counseling, or support
• Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
• Family counseling
• Smoking/vaping/tobacco cessation counseling
• Group counseling

Age Groups Accepted

• Adults
• Young Adults

Recovery Support Services

• Employment counseling or training
• Housing services
• Recovery coach
• Mentoring/peer support
• Self-help groups
• Assistance with obtaining social services

External Opioid Medications Source

• In-network prescribing entity

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Language Services

• Sign language services for the deaf and hard of hearing

Transitional Services

• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care

License/Certification/Accreditation

• The Joint Commission
• State Substance use treatment agency
• State mental health department

Assessment/Pre-treatment

• Complete medical history/physical exam
• Outreach to persons in the community
• Interim services for clients
• Comprehensive mental health assessment
• Screening for substance use
• Screening for tobacco use
• Comprehensive substance use assessment
• Screening for mental disorders

Pharmacotherapies

• Medication for mental disorders
• Buprenorphine (extended-release, injectable)
• Acamprosate (Campral�)
• Naltrexone (oral)
• Clonidine
• Buprenorphine without naloxone
• Buprenorphine with naloxone
• Naltrexone (extended-release, injectable)